CLL cells exprimed Notch pathway molecules, receptors NOTCH1 and NOTCH2 and ligand JAGGED1, as well as HES1, a downstream Notch target, indicating unusual activity of the pathway. This evidence concerns the gene NOTCH2 and B-cell chronic lymphocytic leukemia.